IGUELLE BERNARD: Open Payments
NPI 1467183517 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,051 in 210 payments from 15 companies in 2025. Trend: 2023 $1,610 · 2024 $2,557 · 2025 $3,051
Food & beverage: $3,051
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 60 | $683 |
| Neurocrine BioSciences, Inc. | 25 | $499 |
| Teva Pharmaceuticals USA, Inc. | 24 | $322 |
| E.R. Squibb & Sons, L.L.C. | 9 | $226 |
| Otsuka America Pharmaceutical, Inc. | 9 | $208 |
| ABBVIE INC. | 26 | $196 |
| Collegium Pharmaceutical, Inc. | 24 | $183 |
| Janssen Pharmaceuticals, Inc | 10 | $178 |
| Alkermes, Inc. | 7 | $137 |
| Lundbeck LLC | 3 | $100 |
Products named: Qelbree, INGREZZA, COBENFY, REXULTI, VRAYLAR, Jornay PM, AUSTEDO XR, UZEDY.
Industry payments across MI — which companies pay providers there.
